 HC Wainwright has cut the price target for Dentsply Sirona Inc NASDAQ: XRAY from 58 to 48 17 upside, reiterating the Neutral rating. The analysts have adjusted 2022 projections to reflect lower than expected Q1 FY22 earnings. 